Stock TSHA TAYSHA GENE THERAPIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Taysha Gene Therapies, Inc.

Equities

TSHA

US8776191061

Market Closed - Nasdaq
Other stock markets
 03:59:52 2024-05-29 pm EDT 		5-day change 1st Jan Change
3.175 USD -2.31% Intraday chart for Taysha Gene Therapies, Inc. +6.90% +79.38%
May. 14 Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours MT
May. 14 Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Taysha Gene Therapies Insider Bought Shares Worth $163,000, According to a Recent SEC Filing
MT
Taysha Gene Therapies, Inc. Appoints Alison Long to Board and Committees
CI
Pliant Therapeutics Appoints Chief Regulatory Officer
MT
Insider Buy: Taysha Gene Therapies
MT
Taysha Gene Therapies, Inc. Announces Board Changes
CI
Taysha Gene Therapies, Inc. Announces Resignation of Kathleen Reape as Director, Effective November 1, 2023
CI
Taysha Gene Therapies, Inc. Announces Resignation of R.A. Session II from the Board and All Committees
CI
Taysha Gene Therapies, Inc. Announces Separation Suyash Prasad as Chief Medical Officer
CI
Taysha Gene Therapies Appoints Sean Nolan as CEO
MT
Taysha Gene Therapies, Inc. Appoints Sukumar Nagendran, M.D. as President and Head of R&D
CI
Taysha Gene Therapies Announces CEO Changes
CI
Insider Buy: Taysha Gene Therapies
MT
Insider Buy: Taysha Gene Therapies
MT
Taysha Gene Therapies Appoints Mary Newman as Chief Development Officer
CI
Taysha Gene Therapies Announces Formation of Independent Scientific Advisory Board
CI
Taysha Gene Therapies, Inc. Appoints Timothy J. Douros as Chief Legal Officer and Corporate Secretary and Tracy M. Porter as Chief People Officer
CI
Taysha Gene Therapies, Inc. Announces Executive Appointments
CI
Taysha Gene Therapies Names Kathy Reape and Laura Sepp-Lorenzino to Board of Directors
CI
Taysha Gene Therapies, Inc Announces Directors Appointments
CI
Taysha Gene Therapies, Inc. Announces Appointments to the Board and Appoints Phillip Donenberg to Serve as Audit Committee Chairman
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TSHA Stock
  4. News Taysha Gene Therapies, Inc.
  5. Insiders